Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy SI-BONE stock | $30.17

Learn how to easily invest in SI-BONE stock.

-$4.49 (-14.84%)

SI-BONE, Inc is a medical devices business based in the US. SI-BONE shares (SIBN) are listed on the NASDAQ and all prices are listed in US Dollars. SI-BONE employs 295 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in SI-BONE

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SIBN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

SI-BONE stock price (NASDAQ: SIBN)

Use our graph to track the performance of SIBN stocks over time.

SI-BONE shares at a glance

Information last updated 2021-07-28.
Latest market close$30.17
52-week range$17.16 - $37.21
50-day moving average $30.65
200-day moving average $31.42
Wall St. target price$41.50
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.53

Buy SI-BONE shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, ETFs
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Options, ETFs
$0 per year
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy SI-BONE stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

SI-BONE price performance over time

Historical closes compared with the close of $30.17 from 2021-05-28

1 week (2021-07-24) N/A
1 month (2021-07-02) -2.05%
3 months (2021-05-04) -8.58%
6 months (2021-01-31) N/A
1 year (2020-07-31) N/A
2 years (2019-07-31) N/A
3 years (2018-07-31) N/A
5 years (2016-07-31) N/A

SI-BONE financials

Revenue TTM $77 million
Gross profit TTM $64.5 million
Return on assets TTM -12.66%
Return on equity TTM -31.06%
Profit margin -56.06%
Book value $4.93
Market capitalisation $970.2 million

TTM: trailing 12 months

Shorting SI-BONE shares

There are currently 1.2 million SI-BONE shares held short by investors – that's known as SI-BONE's "short interest". This figure is 10.6% up from 1.0 million last month.

There are a few different ways that this level of interest in shorting SI-BONE shares can be evaluated.

SI-BONE's "short interest ratio" (SIR)

SI-BONE's "short interest ratio" (SIR) is the quantity of SI-BONE shares currently shorted divided by the average quantity of SI-BONE shares traded daily (recently around 285841.83168317). SI-BONE's SIR currently stands at 4.04. In other words for every 100,000 SI-BONE shares traded daily on the market, roughly 4040 shares are currently held short.

However SI-BONE's short interest can also be evaluated against the total number of SI-BONE shares, or, against the total number of tradable SI-BONE shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case SI-BONE's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 SI-BONE shares in existence, roughly 30 shares are currently held short) or 0.0326% of the tradable shares (for every 100,000 tradable SI-BONE shares, roughly 33 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against SI-BONE.

Find out more about how you can short SI-BONE stock.

SI-BONE share dividends

We're not expecting SI-BONE to pay a dividend over the next 12 months.

SI-BONE share price volatility

Over the last 12 months, SI-BONE's shares have ranged in value from as little as $17.16 up to $37.21. A popular way to gauge a stock's volatility is its "beta".

SIBN.US volatility(beta: 1.43)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while SI-BONE's is 1.4326. This would suggest that SI-BONE's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

SI-BONE overview

SI-BONE, Inc. , a medical device company, develops implantable devices used in the surgical treatment of the sacropelvic anatomy in the United States and Internationally. The company offers iFuse, a minimally invasive surgical implant system, which is intended to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California. .

Frequently asked questions

What percentage of SI-BONE is owned by insiders or institutions?
Currently 1.9% of SI-BONE shares are held by insiders and 101.599% by institutions.
How many people work for SI-BONE?
Latest data suggests 295 work at SI-BONE.
When does the fiscal year end for SI-BONE?
SI-BONE's fiscal year ends in December.
Where is SI-BONE based?
SI-BONE's address is: 471 El Camino Real, Santa Clara, CA, United States, 95050
What is SI-BONE's ISIN number?
SI-BONE's international securities identification number is: US8257041090
What is SI-BONE's CUSIP number?
SI-BONE's Committee on Uniform Securities Identification Procedures number is: 825704109

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site